We shown that, in distinction to classical opioid receptors, ACKR3 won't induce classical G protein signaling and is not modulated by the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Instead, we set up that LIH383, an ACKR3-selective subnanomolar competitor https://alexanderx813dyc5.ageeksblog.com/profile